{
  "case_id": "EI07-6949",
  "year": 2007,
  "patient_info": {
    "age_range": "65+",
    "gender": "Female"
  },
  "diagnosis": "Immuno Disorders",
  "secondary_conditions": [],
  "complications": [],
  "symptoms": [],
  "treatment_category": "Pharmacy",
  "treatment_subcategory": "Other",
  "treatments_requested": [
    {
      "name": "Methotrexate",
      "drug_type": "experimental",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": "Requested for treatment of lupus anti-coagulant-type syndrome"
    }
  ],
  "treatments_tried_but_failed": [],
  "treatments_tried_and_worked": [
    {
      "name": "Methotrexate",
      "drug_type": "standard",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": "Achieved good results but not tolerated"
    }
  ],
  "treatments_not_tried": [],
  "is_denial_upheld": false,
  "issues_considered": [
    "medical_necessity",
    "plan_coverage"
  ],
  "other_issues": null,
  "guidelines_support": true,
  "guidelines_not_support": null,
  "guidelines_details": "Methotrexate is appropriate for undifferentiated connective tissue disease per relevant literature.",
  "soc_support": true,
  "soc_not_support": null,
  "soc_details": "Injectable methotrexate is clinically appropriate and indicated for this patient.",
  "study_support": true,
  "study_details": [
    {
      "study_name": "Relevant Literature",
      "study_authors": "Three physician reviewers",
      "key_findings": "Methotrexate is appropriate for undifferentiated connective tissue disease."
    }
  ],
  "key_questions": [
    "medical_necessity",
    "plan_coverage"
  ],
  "expedited": false,
  "rationale": "Injectable methotrexate is clinically appropriate and indicated for this patient due to intolerance to oral form and good results achieved with methotrexate.",
  "reviewer_credentials": null
}